Liver Cancer Treatment Options
Understanding the available liver cancer treatment options helps patients and families make sense of a complex diagnosis. This overview covers current surgical and non-surgical approaches, from resection and transplantation to targeted therapy, immunotherapy, and local procedures.
Key Takeaways
- Liver cancer treatment is highly individualized: cancer stage, how much the liver itself is already affected (often described by cirrhosis severity), and a patient’s general condition all shape which options are appropriate.
- Surgical options, partial hepatectomy or liver transplantation, offer the best chance of cure but are generally limited to patients with early-stage disease and adequate liver function.
- Non-surgical local treatments, including ablation and transarterial chemoembolization (TACE), can control tumors when surgery is not an option.
- Targeted therapy and immunotherapy, including the FDA-approved atezolizumab-bevacizumab combination, are now standard options for more advanced liver cancer.
- A multidisciplinary team, typically including hepatologists, oncologists, surgeons, and radiologists, helps match each patient to the most appropriate combination of treatments.
Overview of Liver Cancer Treatment Approaches
Liver cancer treatment options span a range of strategies, from procedures that remove or destroy the tumor directly to systemic drugs that work throughout the body. Hepatocellular carcinoma, the most common form of primary liver cancer, most often develops in a liver already affected by cirrhosis, so treatment planning has to weigh the cancer itself alongside the health of the remaining liver tissue. A team of specialists, including surgeons, oncologists, hepatologists, and radiologists, typically works together to recommend an approach suited to each patient’s situation.
Factors Influencing Treatment Choice
Several factors guide the selection of appropriate types of treatments for liver cancer:
- Stage and extent of disease: tumor size, number of tumors, and whether cancer has spread beyond the liver affect which treatments are possible; staging details are covered separately.
- Liver function: because many treatments can further stress the liver, doctors assess the severity of any underlying cirrhosis, often using the Child-Pugh classification, to judge what a patient can safely tolerate.
- Overall health: other medical conditions, age, and general fitness influence which treatments a patient can withstand.
- Patient preferences: personal values and goals are part of shared decision-making with the care team.
- Tumor characteristics: specific features of the tumor can sometimes point toward particular targeted therapies.
Surgical Interventions for Liver Cancer
For patients with early-stage liver cancer and enough healthy liver tissue remaining, surgery offers the most direct path to a cure.
Liver Resection
Partial hepatectomy removes the portion of the liver containing the tumor while leaving as much healthy tissue as possible; the remaining liver can often regrow over time. This approach is generally considered for patients with a single tumor or a few small tumors confined to the liver, whose remaining liver tissue is healthy enough to take over full function afterward.
Liver Transplantation
Liver transplantation replaces the entire diseased liver with a healthy donor liver, addressing both the cancer and any underlying cirrhosis at once. Eligibility is commonly guided by criteria such as having a single tumor smaller than 5 centimeters, or two to three tumors each smaller than 3 centimeters; transplant may also be considered instead of resection when cirrhosis is more advanced. The main obstacles are the limited supply of donor organs and the need for lifelong immunosuppressive medication afterward.
Non-Surgical Therapies for Liver Cancer
When surgery is not an option, or alongside it, several non-surgical liver cancer treatments can control tumor growth or relieve symptoms.
Targeted & Immunotherapy
Targeted therapy drugs interfere with specific pathways that cancer cells use to grow. Sorafenib and lenvatinib are established options for advanced liver cancer, with regorafenib and other agents used when initial treatment stops working. Immunotherapy uses the immune system to attack cancer cells; for many patients with advanced disease, the FDA-approved combination of atezolizumab and bevacizumab is now a standard first option because it has outperformed sorafenib alone in clinical trials, and regimens such as nivolumab or pembrolizumab may also be used. These systemic drugs carry their own side effects and are typically reserved for cancer that has spread or cannot be treated locally.
Ablation & Embolization Techniques
These localized treatments target the tumor directly, sparing more of the surrounding liver.
- Radiofrequency ablation (RFA): a thin needle delivers heat generated by high-frequency energy directly into the tumor to destroy it.
- Microwave ablation: microwave energy heats and destroys tumor tissue and can be an option for somewhat larger tumors.
- Cryoablation: extreme cold, delivered through a probe, freezes and destroys cancer cells.
- Transarterial chemoembolization (TACE): a catheter delivers chemotherapy into the artery feeding the tumor and then blocks that blood supply, concentrating the drug near the tumor while limiting its reach elsewhere in the body.
These techniques are often used for tumors that cannot be surgically removed, as a way to control disease while a patient waits for transplant, or to slow progression when other options are not suitable.
Radiation and Systemic Chemotherapy
These approaches play a supporting, or in some cases primary, role when local procedures or surgery are not suitable.
Radiation Therapy Techniques
Stereotactic body radiation therapy (SBRT) delivers precisely targeted, high-dose radiation over a small number of sessions and is now considered a standard option for hepatocellular carcinoma, including as a way to control a tumor before transplant. Proton beam therapy is another approach that may lower the radiation dose reaching healthy liver tissue while still treating the tumor, and some centers are comparing photon-based and proton-based radiation in ongoing research.
Chemotherapy Regimens
Traditional cytotoxic chemotherapy for liver cancer given throughout the body has not been shown to improve survival for advanced hepatocellular carcinoma compared with supportive care alone, which is a major reason targeted therapy and immunotherapy have largely taken its place in that setting. Chemotherapy plays a larger role for cholangiocarcinoma (bile duct cancer), a related but distinct type of liver cancer, where combinations such as gemcitabine and cisplatin are commonly used for disease that cannot be removed surgically.
Latest Advancements in Liver Cancer Treatment
Emerging Therapies & Clinical Trials
Research into new drug combinations, additional immune-based approaches, and refined interventional techniques is ongoing, and clinical trials give some patients access to options not yet in routine use. A closer look at where this research stands belongs on our latest research page; discussing trial participation with the care team is a reasonable step for patients weighing all available options.
Frequently Asked Questions
What factors determine the best liver cancer treatment for an individual?
The right liver cancer treatment depends mainly on the cancer’s stage, how well the rest of the liver is functioning (especially the degree of any cirrhosis), and the patient’s overall health. Tumor characteristics and personal preferences also factor in, and a multidisciplinary team evaluation helps tailor the plan.
Are there new treatments for advanced liver cancer?
Yes. Targeted therapies and immunotherapies, including the atezolizumab-bevacizumab combination, have become standard options for advanced liver cancer and have shown better outcomes than older sorafenib-alone regimens in clinical trials. Combination approaches continue to be studied for further gains.
How do non-surgical treatments for liver cancer work?
Non-surgical liver cancer treatments work through different mechanisms. Ablation methods like RFA use heat or cold to destroy tumor tissue directly, while TACE cuts off a tumor’s blood supply and delivers chemotherapy locally. Targeted therapies block specific pathways tumor cells rely on to grow, and immunotherapies help the immune system recognize and attack cancer cells. These approaches are often used when surgery is not possible or as part of a broader treatment plan.
Sources
